Safety and Therapeutic Optimization of Lutetium-177 Based Radiopharmaceuticals

• Main Authors: Typhanie Ladrière (Author), Julie Faudemer (Author), Elise Levigoureux (Author), Damien Peyronnet (Author), Cédric Desmonts (Author), Jonathan Vigne (Author)
• Format: Book
• Published: MDPI AG, 2023-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Peptide receptor radionuclide therapy (PRRT) using Lutetium-177 (¹⁷⁷Lu) based radiopharmaceuticals has emerged as a therapeutic area in the field of nuclear medicine and oncology, allowing for personalized medicine. Since the first market authorization in 2018 of [¹⁷⁷Lu]Lu-DOT...